Evidence map›Paper›PMID 31059864›Full record

ArticleBone2019

Time course of rapid bone loss and cortical porosity formation observed by longitudinal μCT in a rat model of CKD.

Erin M B McNerny, Dorothy T Buening, Mohammad W Aref, Neal X Chen, Sharon M Moe, Matthew R Allen

Open access · greenAbstract read
In one paragraph

Article in Bone, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Erin M B McNernyDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, United States.
Dorothy T BueningDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, United States; Alma College, Alma, MI, United States.
Mohammad W ArefDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, United States.
Neal X ChenDepartment of Medicine, Division of Nephrology, Indiana University School of Medicine, Indianapolis, IN, United States.
Sharon M MoeDepartment of Medicine, Division of Nephrology, Indiana University School of Medicine, Indianapolis, IN, United States; Roudebush Veterans Administration Medical Center, Indianapolis, IN, United States.
Matthew R AllenDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, United States; Department of Medicine, Division of Nephrology, Indiana University School of Medicine, Indianapolis, IN, United States; Department of Biomedical Engineering, Indiana University Purdue University of Indianapolis, Indianapolis, IN, United States; Roudebush Veterans Administration Medical Center, Indianapolis, IN, United States. Electronic address: matallen@iupui.edu.
Indiana University School of MedicineAlma College · USRichard L. Roudebush VA Medical Center · USUniversity of Indianapolis · US

Funding

Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Pathogenesis of compromised bone quality and mechanics in chronic kidney disease.R01DK110871 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI ALLEN, MATTHEW R, MOE, SHARON M · 2016 to 2019
$1.8M
Assessing and improving bone quality in chronic kidney diseaseF32DK108554 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI MCNERNY, ERIN MARGARET BRONTE · 2015 to 2017
$170k
Bone vascular alterations in chronic kidney diseaseF30DK115162 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI AREF, MOHAMMAD WALID · 2017 to 2020
$160k
NCATS NIH HHS UL1 TR002529NIDDK NIH HHS F30 DK115162NIDDK NIH HHS F32 DK108554NIDDK NIH HHS R01 DK110871
6 · The paper itself

Abstract

backgroundRodent studies of bone in chronic kidney disease have primarily relied on end-point examinations of bone microarchitecture. This study used longitudinal in vivo microcomputed tomography (in vivo μCT) to characterize the onset and progression of bone loss, specifically cortical porosity, in the Cy/+ rat of model of CKD.

methodsMale CKD rats and normal littermates were studied. In vivo μCT scans of the right distal tibia repeated at 25, 30, and 35 weeks were analyzed for longitudinal changes in cortical and trabecular bone morphometry. In vitro μCT scans of the tibia and femur identified spatial patterns of bone loss across distal, midshaft and proximal sites.

resultsCKD animals had reduced BV/TV and cortical BV at all time points but developed cortical porosity and thinning between 30 and 35 weeks. Cortical pore formation was localized near the endosteal surface. The severity of bone loss was variable across bone sites, but the distal tibia was representative of both cortical and trabecular changes.

conclusionsThe distal tibia was found to be a sensitive suitable site for longitudinal imaging of both cortical and trabecular bone changes in the CKD rat. CKD trabecular bone loss progressed through ~30 weeks followed by a sudden acceleration in cortical bone catabolism. These changes varied in timing and severity across individuals, and cortical bone loss and porosity progressed rapidly once initiated. The inclusion of longitudinal μCT in future studies will be important for both reducing the number of required animals and to track individual responses to treatment.

Indexed as

AnimalsBone DensityBone Diseases, MetabolicCortical BoneFemurMaleRatsRenal Insufficiency, ChronicTibiaX-Ray MicrotomographyCKD-MBDIn vivo microcomputed tomographyLongitudinal imagingRat modelsRenal osteodystrophy

Identifiers

PMID31059864
PMCPMC6581598
OpenAlexW2943210990

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.